Using cyclosporine in the COVID era: An emergent need for caution.
作者信息
Khurana Ananta, Sethia Khushboo
机构信息
Department of Dermatology, Dr. Ram Manohar Lohia Hospital & Atal Bihari Vajpayee Institute of Medical Sciences, New Delhi, India.
Department of Dermatology, Dr. Ram Manohar Lohia Hospital & Atal Bihari Vajpayee Institute of Medical Sciences, New Delhi, India.
出版信息
J Am Acad Dermatol. 2020 Oct;83(4):e315-e316. doi: 10.1016/j.jaad.2020.06.990. Epub 2020 Jun 27.
Abstract
摘要
相似文献
1
Using cyclosporine in the COVID era: An emergent need for caution.在新冠疫情时代使用环孢素：迫切需要谨慎。
J Am Acad Dermatol. 2020 Oct;83(4):e315-e316. doi: 10.1016/j.jaad.2020.06.990. Epub 2020 Jun 27.
2
Immunosuppressive drugs for patients with psoriasis during the COVID-19 pandemic era. A review.COVID-19 大流行时期银屑病患者的免疫抑制药物。综述。
Dermatol Ther. 2021 Jan;34(1):e14498. doi: 10.1111/dth.14498. Epub 2020 Nov 10.
3
Simultaneous Inhibition of SARS-CoV-2 Entry Pathways by Cyclosporine.环孢素同时抑制 SARS-CoV-2 的进入途径。
ACS Chem Neurosci. 2021 Mar 3;12(5):930-944. doi: 10.1021/acschemneuro.1c00019. Epub 2021 Feb 19.
4
SARS-CoV-2 reactive infectious mucocutaneous eruptions in adults treated with cyclosporine as first line treatment.接受环孢素作为一线治疗的成人中出现的SARS-CoV-2反应性感染性皮肤黏膜疹。
J Dtsch Dermatol Ges. 2024 Jul;22(7):1013-1015. doi: 10.1111/ddg.15417. Epub 2024 Jun 4.
5
Comment on "COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action".关于《COVID-19与银屑病：是时候限制免疫抑制剂治疗了吗？行动呼吁》的评论
Dermatol Ther. 2020 Jul;33(4):e13360. doi: 10.1111/dth.13360. Epub 2020 Apr 16.
6
Psoriasis and psoriatic arthritis: How to manage immunosuppressants in COVID-19 days.银屑病和银屑病关节炎：在新冠疫情期间如何管理免疫抑制剂
Dermatol Ther. 2020 Jul;33(4):e13415. doi: 10.1111/dth.13415. Epub 2020 May 2.
7
COVID-19 and the digestive system: protection and management during the SARS-CoV-2 pandemic.COVID-19 与消化系统：SARS-CoV-2 大流行期间的保护和管理。
Rev Esp Enferm Dig. 2020 May;112(5):389-396. doi: 10.17235/reed.2020.7128/2020.
8
[Rheumatology and COVID-19].[风湿病学与新型冠状病毒肺炎]
Rev Med Suisse. 2020 Apr 29;16(N° 691-2):831-834.
9
COVID-19 in a young liver transplant recipient: caution for drug-drug interactions.一名年轻肝移植受者的新型冠状病毒肺炎：警惕药物相互作用
J Gastrointestin Liver Dis. 2020 Sep 9;29(3):470. doi: 10.15403/jgld-2672.
10
Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug-Drug Interactions.移植受者感染 SARS-CoV-2 的药物治疗：治疗药物监测和药物相互作用的考虑因素。
Ther Drug Monit. 2020 Jun;42(3):360-368. doi: 10.1097/FTD.0000000000000761.
引用本文的文献
1
Dealing with Corticosteroid and High-Dose Cyclosporine Therapy in a Pyoderma Gangrenosum Patient Contracting a COVID-19 Infection.一名患有坏疽性脓皮病的患者感染新冠病毒后接受皮质类固醇和大剂量环孢素治疗的应对措施
J Pers Med. 2022 Jan 27;12(2):173. doi: 10.3390/jpm12020173.
2
Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants.环孢素 A 通过三种 SARS-CoV-2 变体抑制肺细胞中的病毒感染和释放以及细胞因子产生。
Microbiol Spectr. 2022 Feb 23;10(1):e0150421. doi: 10.1128/spectrum.01504-21. Epub 2022 Jan 5.
本文引用的文献
1
Immunosuppressive agents for dermatological indications in the ongoing COVID-19 pandemic: Rationalizing use and clinical applicability.在持续的 COVID-19 大流行期间用于皮肤科适应证的免疫抑制剂：合理使用和临床适用性。
Dermatol Ther. 2020 Jul;33(4):e13639. doi: 10.1111/dth.13639. Epub 2020 Jun 23.
2
Cyclosporine therapy during the COVID-19 pandemic.新冠疫情期间的环孢素治疗。
J Am Acad Dermatol. 2020 Aug;83(2):e151-e152. doi: 10.1016/j.jaad.2020.04.153. Epub 2020 May 4.
3
Interferon-β and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays.干扰素-β和吗替麦考酚酯在基于细胞的检测中是中东呼吸综合征冠状病毒的有效抑制剂。
J Gen Virol. 2014 Mar;95(Pt 3):571-577. doi: 10.1099/vir.0.061911-0. Epub 2013 Dec 9.
4
Cyclophilin inhibitors: a novel class of promising host-targeting anti-HCV agents.亲环素抑制剂：一类有前途的新型宿主靶向抗 HCV 药物。
Immunol Res. 2012 Jun;52(3):200-10. doi: 10.1007/s12026-011-8263-5.
5
The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors.严重急性呼吸综合征冠状病毒-宿主相互作用组：亲环素作为泛冠状病毒抑制剂的靶标鉴定。
PLoS Pathog. 2011 Oct;7(10):e1002331. doi: 10.1371/journal.ppat.1002331. Epub 2011 Oct 27.
6
Cyclosporin A inhibits the replication of diverse coronaviruses.环孢素 A 抑制多种冠状病毒的复制。
J Gen Virol. 2011 Nov;92(Pt 11):2542-2548. doi: 10.1099/vir.0.034983-0. Epub 2011 Jul 13.
7
Thiopurine analogue inhibitors of severe acute respiratory syndrome-coronavirus papain-like protease, a deubiquitinating and deISGylating enzyme.严重急性呼吸综合征冠状病毒木瓜样蛋白酶的硫嘌呤类似物抑制剂，一种去泛素化和去ISGylation酶
Antivir Chem Chemother. 2009;19(4):151-6. doi: 10.1177/095632020901900402.
8
Infection and cyclosporine.感染与环孢素
Rev Infect Dis. 1989 Sep-Oct;11(5):677-90. doi: 10.1093/clinids/11.5.677.
Zotero 插件